2020 Partners To Date
We want to be your partner and drive pioneering therapies to the market. We invest in enabling technologies and build expertise to support the development and commercialization of your new innovative therapy. Our scientists and engineers bring decade-long development experience across a broad spectrum of cell types and technologies. This builds the backbone of an extensive service offering, providing you with tailored process and analytical development, manufacturing and regulatory services.
Covance Inc., the drug development business of Laboratory Corporation of America Holdings (LabCorp) headquartered in Princeton, New Jersey, USA, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®. Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, helps our clients identify new approaches and anticipate tomorrow’s challenges as they evolve. Together with our clients, Covance transforms today’s healthcare challenges into tomorrow’s solutions.
BIA Separations has 20 years’ experience in chromatographic purification. Our products, CIM monoliths, were designed with unique operating properties that make them ideally suited to the challenging requirements of purifying biomolecules such as virus particles, vesicles, proteins, RNA’s, plasmids and other forms of DNA. We provide products that range from small analytical columns to large industrial prep-scale columns (including cGMP and disposable units) as well as method development services.
Project Farma is an industry leader in providing project management, validation, engineering and consulting services with a proven track record in gene and cell therapy. We partner with cell and gene therapy organizations in addition to healthcare, pharmaceutical, bio-pharmaceutical companies to support finding ground-breaking treatments and solutions. Our clients include startups, small and large pharmaceutical and biotech companies and CMOs/ CROs. We are committed to helping advance cuttingedge medicines by leveraging our deep knowledge and broad experience in cell and gene therapy to meet any new challenges. With over 200 employees, our business infrastructure enables robust scalability to ensure that the proper resources are available to support the project.
Brammer Bio is dedicated to providing clinical and commercial viral vectors for in vivo gene and ex vivo gene-modified cell therapies, from process and analytical development through commercial approval. We have a highly skilled team of scientists with expertise from over 100 client projects to tackle the challenges posed by these novel technologies and help accelerate their transition from the clinic to patients, while focusing on meeting cGMP standards. Brammer Bio is Helping to Cure.®
Polyplus-transfection applies its 15+ year expertise to the development of novel transfection solutions up to GMP grade for high yield transient protein and antibody production in CHO and HEK-293 cells, as well as for viral vector production for Gene and Cell Therapy (PEIpro product range).
Patients First – it’s in our DNA. At CareMetx, we fight for every patient “from intake to outcomes” by providing Hub/reimbursement services, leading-class technology and strategic consulting to accelerate access to lifesaving treatments. Speed and efficiency – is why we’re different. CareMetx leverages our expertise and innovative patient eAccess technology to revolutionize the patient experience. We partner with our clients to launch or transition pharmaceutical programs in record time with significant cost savings.
Trinity is a global life sciences strategy consulting company. We partner with leading pharmaceutical, biotech, and medical device / diagnostic companies to provide best-in-class strategic support and evidencebased insights. Our support spans the lifecycle of development from early stage pipeline assets to life cycle management across a diverse type of business questions. Trinity’s experience touches all types of markets, with orphan/rare diseases being one of our top markets of focus. Our expertise in gene and cell therapy is driven by our commercial understanding of the markets and our scientific background, coupled with deep experience supporting many clients at the forefront of these therapies.
MolMed is a biotech company focused on innovative cell and gene therapies that can meet the therapeutic needs in the treatment of tumors and rare diseases, by combining scientific and research excellence with clear and strong industrial projects. With two approved manufacturing facilities (about 4.800 SQM) and top level expertise, MolMed offers platforms of lentiviral and retroviral vector manufacturing with different scales and a consolidated processes in cells engineering (Hematopoietic Stem cells and T-cells).
VGXI, Inc. is a leading plasmid DNA CDMO with nearly 20 years of experience providing exceptional quality products to clinical trials worldwide. The company's continuous, low-shear AIRMIX® lysis technology and optimized purification process provide highly supercoiled plasmid with exceptional purity across all manufacturing scales. Production services include high purity plasmid for preclinical research, Highly Documented (HD) plasmid for GMP viral vector production or pharm/tox studies, and cGMP plasmid DNA for clinical through commercial supply.
Beacon Hill Pharma
Beacon Hill Pharma, Beacon Hill’s Life Sciences specialty division, partners with Gene Therapy, Pharmaceutical, Biotech, Medical Device, Diagnostics, Clinical Research Outsourcing, and other corporations delivering the most qualified Life Sciences resourcing solutions in the market today. Committed to identifying and delivering qualified candidates that fit your objectives and company culture, we place Life Sciences contractors in all 50 states, seamlessly coordinating recruiting resources in local and regional markets with Beacon Hill Pharma’s National Recruiting & Delivery.
Vigene Biosciences’ mission is to Make Gene Therapy Affordable. Headquartered in Rockville, MD, Vigene offers FDA and EMA compliant cGMP production for AAV, lentivirus, adenovirus. With a proven record of cGMP grade AAV, lentivirus and adenovirus production, Vigene is combining the proven production technologies with rigorous regulatory compliant cGMP production to meet the needs and expectations of clinical material clients. Globally Vigene is proud to serve over 1000 academic, biotech and pharmaceutical labs.
Rho, a contract research organization (CRO) located in Chapel Hill, NC, provides a full range of services across the entire drug development process. For more than 30 years, Rho has been a trusted partner to leading pharmaceutical, biotechnology, and medical device companies as well as academic and government organizations. Our commitment to excellence, innovative technologies, and therapeutic expertise accelerate time to market, maximize returns on investment, and lead to an exceptional customer experience.
QPS is a global, science driven, customer-focused CRO that provides preclinical studies and clinical trials to the biotech and pharmaceutical industries. Our 1100+ person organization has expertise in nearly all drug modalities including small molecules, proteins, and other biotherapeutics. We have supported gene therapy since 2002: ASOs, siRNAs, miRNA through mRNAs and viral vectors. Our bioanalytical technologies include LC-HRMS, hybridization-LC, and qPCR; while our full spectrum DMPK services covers PK, DDI, biodistribution, and radiolabel studies.
Paragon Bioservices is an industry-leading, privateequity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon aims to build strong client partnerships with the world’s best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic proteins, and other complex
An independent pharmacy and services provider, Anovo is dedicated to rare disease therapies and the people who rely upon them. Anovo provides specialty pharmacy, Hub, 3PL/Title model and distribution services all under one roof.
Therapy-dedicated teams offer reimbursement support, therapy education, and delivery services to enable quick, convenient and courteous access to therapy along with a positive therapy journey.
Our success is due to the time we invest in listening and collaborating with our manufacturer partners to develop custom programs that align with your goals and patient needs.
Delphi Genetics is a private biotech company with proven track record in genetic engineering and bioproduction. The company provides one-stop-shop service from development to GMP manufacturing of plasmid DNA for Cell & Gene Therapy applications, with a focus on DNA for viral vectors. Delphi Genetics has developed an innovative antibiotic-free technology (Staby®). Staby technology meets regulatory guidelines and drives a better plasmid DNA stabilization, and has been non-exclusively licensed to several big pharmaceutical companies.
Ology Bioservices, Inc. (Ology Bio) is a biologics-focused CDMO serving both government and commercial clients from its three US locations: Alachua, FL; Alameda, CA; & Frederick, MD. Ology Bio’s capabilities include cell & virus banking, process development/optimization, cGMP manufacturing, analytical & bioanalytical development and testing, and full regulatory support of antibodies, cell & gene therapies, proteins, and viral vaccines. Ology Bio provides expertise from preclinical stage through FDA licensure, and offers licensing of proprietary cell lines.